- About Us
- Get Involved
- Learn About Drug & Device Approval
- Learn About Clinical Trials
- Learn About Treatment Options
- Get Illness/Condition Information
- Ask the FDA
- + About Us
- + Get Involved
- + Learn About Drug & Device Approval
- + Learn About Clinical Trials
- + Learn About Treatment Options
- + Get Illness/Condition Information
- Ask the FDA
FDA and Cancer Treatment
We work with FDA’s oncology (cancer) medical staff to bring your perspective into the review of new drugs to treat or prevent cancer. We also meet with organized patient advocacy groups to hear their concerns about drug development and to assist them in understanding the FDA drug regulatory process. You and your loved ones can contact the Office of Health and Constituent Affairs with questions about cancer clinical trials or cancer drug development.
Consider other options when cancer treatments are not working.
Information about Chemotherapy and Biologic Therapy
Learn about the medicines you take and about the FDA approved labeling
Important Updates from the National Cancer Institute
The Changing Landscape of Clinical Trials
The National Cancer Institute's clinical trials system is changing. The new system will allow clinical trials to begin more quickly, reach conclusions faster, and offer patients studies that incorporate precision medicine, which uses information about a person’s tumor to help diagnose and treat cancer.
- An open letter from NCI Director Harold Varmus, M.D.
- Forthcoming changes in NCI's clinical trials programs
- Implementation of NCI's National Clinical Trials Network
Reducing Cancer Health Disparities
Minorities and people living in underserved communities are disproportionately affected by cancer, for reasons that need to be better understood and addressed. Through research, education, and training, NCI and its partners are working to reduce cancer health disparities.